Luc Cabel retweetledi

🆕article in press: Kinetics and determinants of ESR1 mutation detection in metastatic breast cancer. @BarbaraPistill2 Read it here: annalsofoncology.org/article/S0923-…

English
Luc Cabel
3 posts




Merck announces positive results for KEYNOTE-756: the addition of pembrolizumab to neoadjuvant chemo significantly improved pCR rate among patients with high-risk HR+/HER2- breast cancer. Follow up ongoing for EFS (co-primary endpoint). Poll below 👇 merck.com/news/merck-ann…

